PINK1:从帕金森病到线粒并再次回来
Benjamin O'Callaghan1,2, John Hardy1,2,3, Helene Plun-Favreau1,2
1Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom.
PLoS biology
|June 29, 2023
概括
帕金森病的遗传学研究揭示了PINK1在线中发挥的关键作用. 这个过程对于清除受损的线粒体至关重要,它的功能障碍与帕金森病的发病有关.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 的发病越来越多地与线粒体功能障碍有关.
- 无素-蛋白酶体系统和线性是关键的细胞质量控制机制.
- 遗传因素对了解PD及其分子基础作出了重大贡献.
研究的目的:
- 为了阐明PINK1在线细胞衰变途径中的功能意义.
- 突出PINK1早期研究的影响及其在PD中的作用.
- 为了将PD中的遗传发现与PINK1-依赖的线粒菌级联联系起来.
主要方法:
- 从一个开创性的2010年PLOS生物学论文的调查结果的审查和讨论.
- 分析PINK1蛋白在启动线粒的作用.
- 对帕金森病和线粒体质量控制的遗传联系的检查.
主要成果:
- 2010年的论文确立了PINK1作为线粒的关键发起者.
- PINK1 积聚在受损的线粒体上,招募其他因素触发其去除.
- 功能失调的PINK1与帕金森病中观察到的受损线粒体的积累有关.
结论:
- 依赖PINK1的线粒是神经元健康的关键途径.
- 了解PINK1的功能对于解开帕金森病遗传学至关重要.
- 准线粒菌通路可能为帕金森病提供治疗策略.
更多相关视频
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
7.9K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.2K
相关概念视频
Translocation of Proteins into the Mitochondria
3.2K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
302
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
302
